The Shot Just Became a Pill. What Every 55+ Reader Should Know Before Asking for It

Foundayo, the first GLP-1 weight-loss pill you can take any time of day, is here. Here's what it does, what it costs, and the questions to bring to your doctor.

By Alan Reyes · Oct 17, 2026 · 6 min read

ShareFacebookXLinkedIn Email

For three years, the weight-loss conversation at every Central Jersey dinner party has started with the same word: the shot. Now there's a pill. On April 1, 2026, the FDA approved Foundayo (orforglipron), the fastest approval of a brand-new drug since 2002.

What it actually is

Foundayo is a once-a-day GLP-1 tablet from Eli Lilly, the same drug family as Ozempic, Wegovy and Zepbound. Lilly calls it the only GLP-1 weight-loss pill you can take any time of day, with or without food or water. That matters if you already juggle morning pills on an empty stomach.

How well it works

In the ATTAIN-1 trial, people on the highest dose lost about 11% of their body weight versus about 2% on placebo, an average of roughly 27 pounds. Waist size, blood pressure, triglycerides and non-HDL cholesterol improved too. That's less than the strongest injectables, but plenty of people will trade a bit of effect for no needles.

What it costs

Lilly lists self-pay pricing starting at $149 a month for the lowest dose, and as little as $25 a month for eligible people with commercial coverage. Higher doses cost more. If you're on Medicare, call your Part D plan first: drugs prescribed only for weight loss have traditionally been excluded, so coverage is the question to settle before you get attached.

The fine print that matters after 55

  • Muscle. Fast weight loss takes muscle with it, and muscle is your fall insurance. Pair any GLP-1 with protein at every meal and strength training twice a week.
  • Stomach side effects. Nausea, constipation and diarrhea are the most common complaints, usually worst while the dose is going up.
  • Thyroid warning. Like the rest of the class, it carries a boxed warning and isn't for anyone with a personal or family history of medullary thyroid cancer or MEN 2.
  • Don't double up. It isn't meant to be combined with another GLP-1.

Five questions for your doctor

  1. Am I a candidate based on my weight and health conditions?
  2. Pill or injection, which fits my other medications?
  3. What's my plan to protect muscle and bone?
  4. What does my plan cover, and what's the cash price at my dose?
  5. What happens if I stop?

This article is for general information, not medical advice. Talk with your own clinician before starting any prescription.

Share a line

Pass this one along

Pick a line, save the card, and send it to whoever needs to read it.

Text itWhatsAppFacebook

“On April 1, 2026, the FDA approved Foundayo (orforglipron), the fastest approval of a brand-new drug since 2002.”

Your next step

Questions about your own retirement?

Talk it through with a licensed advisor on our team. Ask your questions, get straight answers, and leave with a clear place to start. No cost, no obligation, nothing sold on the call.

Run your own numbers

The Let’s Start tool

Prefer to try it yourself first? It’s a calculator that sets a retirement income target and shows how much savings could support it.

Open the Let’s Start →

Advisory and insurance services are provided by licensed professionals; availability varies by state.

Straight talk or nonsense? One tap tells us. 0 comments

The Conversation

No comments yet. Tell us where we got it right — or where we're dead wrong.

Comments are for members — it keeps the spam out and the conversation honest.

Create a free account
Advertise with us — article-inline

The newsletter

Get the good stuff every week.

The best takes, columns, and local finds — sent straight to your inbox. Free, no fluff, unsubscribe whenever.

By subscribing you agree to receive emails from Second Act 360.